DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,110,167 shares; 2025Q1: 2,341,667 shares; 2025Q2: 2,341,667 shares; 2025Q3: 2,416,667 shares; 2025Q4: 2,416,667 shares; 2026Q1: 1,946,667 shares; 2026Q2: 1,841,667 shares; 2026Q3: 1,686,667 shares 1,686,667 $149M 20.07% -155,000 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,230,000 shares; 2025Q2: 1,267,000 shares; 2025Q3: 1,325,000 shares; 2025Q4: 756,000 shares; 2026Q1: 677,000 shares; 2026Q2: 993,000 shares; 2026Q3: 993,000 shares 993,000 $98.3M 13.29% 0 Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,440,000 shares; 2026Q2: 2,950,000 shares; 2026Q3: 2,511,000 shares 2,511,000 $95.6M 12.91% -439,000 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,763,000 shares; 2025Q1: 2,763,000 shares; 2025Q2: 2,763,000 shares; 2025Q3: 2,874,111 shares; 2025Q4: 2,350,000 shares; 2026Q1: 2,350,000 shares; 2026Q2: 2,350,000 shares; 2026Q3: 2,350,000 shares 2,350,000 $75.2M 10.17% 0 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,059,387 shares; 2025Q1: 2,059,387 shares; 2025Q2: 1,946,054 shares; 2025Q3: 1,971,054 shares; 2025Q4: 1,971,054 shares; 2026Q1: 1,971,054 shares; 2026Q2: 1,971,054 shares; 2026Q3: 2,141,387 shares 2,141,387 $64.8M 8.76% +170,333 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,450,000 shares; 2025Q1: 10,700,000 shares; 2025Q2: 12,592,500 shares; 2025Q3: 9,067,500 shares; 2025Q4: 8,859,911 shares; 2026Q1: 8,859,911 shares; 2026Q2: 9,693,244 shares; 2026Q3: 9,693,244 shares 9,693,244 $47.2M 6.38% 0 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,414,610 shares 2,414,610 $33.2M 4.48% new Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 266,000 shares; 2025Q3: 360,000 shares; 2025Q4: 535,000 shares; 2026Q1: 425,000 shares; 2026Q2: 310,000 shares; 2026Q3: 205,000 shares 205,000 $22.9M 3.1% -105,000 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 270,000 shares; 2026Q2: 270,000 shares; 2026Q3: 270,000 shares 270,000 $17.7M 2.39% 0 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 630,000 shares 630,000 $15.7M 2.12% new Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 490,000 shares; 2026Q2: 490,000 shares; 2026Q3: 420,000 shares 420,000 $15.6M 2.11% -70,000 Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 934,716 shares; 2026Q3: 934,716 shares 934,716 $15M 2.02% 0 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 338,900 shares; 2026Q2: 338,900 shares; 2026Q3: 169,450 shares 169,450 $14.5M 1.96% -169,450 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 960,847 shares; 2026Q2: 960,847 shares; 2026Q3: 713,000 shares 713,000 $13.9M 1.88% -247,847 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,567,898 shares; 2026Q1: 10,276,317 shares; 2026Q2: 10,276,317 shares; 2026Q3: 10,276,317 shares 10,276,317 $13.9M 1.87% 0 Timeline BIOA BIOAGE LABS INC More: the full row for BIOAGE LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,598,000 shares; 2026Q1: 1,748,000 shares; 2026Q2: 1,748,000 shares; 2026Q3: 1,300,000 shares 1,300,000 $9.22M 1.25% -448,000 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 778,000 shares; 2025Q1: 769,815 shares; 2025Q2: 672,595 shares; 2025Q3: 722,595 shares; 2025Q4: 671,465 shares; 2026Q1: 165,000 shares; 2026Q2: 456,721 shares; 2026Q3: 249,000 shares 249,000 $7.9M 1.07% -207,721 Timeline GYRE GYRE THERAPEUTICS INC More: the full row for GYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 954,416 shares; 2026Q3: 954,416 shares 954,416 $7M 0.95% 0 Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,018,021 shares; 2025Q3: 1,018,021 shares; 2025Q4: 574,200 shares; 2026Q1: 574,200 shares; 2026Q2: 574,200 shares; 2026Q3: 574,200 shares 574,200 $6.75M 0.91% 0 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,425,000 shares; 2025Q1: 2,425,000 shares; 2025Q2: 2,425,000 shares; 2025Q3: 2,624,000 shares; 2025Q4: 2,623,600 shares; 2026Q1: 3,166,600 shares; 2026Q2: 2,075,000 shares; 2026Q3: 599,900 shares 599,900 $4.6M 0.62% -1,475,100 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,322,000 shares; 2025Q2: 3,672,000 shares; 2025Q3: 2,815,000 shares; 2025Q4: 2,815,000 shares; 2026Q1: 1,485,000 shares; 2026Q2: 315,000 shares; 2026Q3: 315,000 shares 315,000 $4.51M 0.61% 0 Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 361,010 shares; 2026Q3: 100,000 shares 100,000 $2.97M 0.4% -261,010 Timeline DTIL PRECISION BIOSCIENCES INC More: the full row for PRECISION BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,917,995 shares; 2026Q1: 2,236,732 shares; 2026Q2: 1,350,000 shares; 2026Q3: 430,000 shares 430,000 $2.69M 0.36% -920,000 Timeline UNCY UNICYCIVE THERAPEUTICS INC More: the full row for UNICYCIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,000,000 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 275,000 shares 275,000 $1.29M 0.17% -725,000 Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 18,350,000 shares; 2025Q1: 18,350,000 shares; 2025Q2: 18,350,000 shares; 2025Q3: 17,050,000 shares; 2025Q4: 13,915,371 shares; 2026Q1: 7,750,000 shares; 2026Q2: 7,750,000 shares; 2026Q3: 96,875 shares 96,875 $1.15M 0.16% -7,653,125 Timeline